ReviewHealthcare (Basel, Switzerland)2025

The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations.

Jonathan Shaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.